New Research Shows Rare Breast Implant Associated Anaplastic Large Cell Lymphoma Can Be Reliably Diagnosed & Surgically Treated
Research Presented at Plastic Surgery The Meeting, Premiere Scientific Meeting for Plastic Surgery
CHICAGO – New research conducted by a team of investigators at MD Anderson Cancer Center and unveiled at Plastic Surgery The Meeting 2015, the American Society of Plastic Surgery's (ASPS) 84th annual plastic surgery conference, shows that breast implant associated anaplastic large cell lymphoma, (BIA-ALCL) a very rare type of lymphoma, can be reliably diagnosed and surgically treated successfully. The study found that when treated appropriately, the majority of patients experienced a good prognosis.
The abstract, presented at The Meeting, "Characteristics and Treatment of Advanced Breast Implant Associated Anaplastic Large Cell Lymphoma," was authored by Meredith Collins, MD1, Mark Clemens, MD2, Charles E. Butler, MD3, Kelly K. Hunt, MD4, L. Jeffrey Medeiros, MD5, Michelle A. Fanale, MD6, Jun Liu, PhD7, and, Roberto N. Miranda, MD8.
In making the announcement, Charles E. Butler, M.D, President-elect of The Plastic Surgery Foundation said "Definitive surgery with implant removal and total capsulectomy appears to be the optimal primary treatment for patients with BIA-ALCL. Overall this is a positive message for the rarity and treatability of the disease."
The FDA has noted that breast implants have a reasonable assurance of safety and efficacy, and has urged all physicians to report confirmed BIA-ALCL cases. It has also collaboraed with ASPS and The PSF to form the Patient Registry and Outcomes For Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE) registry as a mechanism to prospectively track patients and outcomes.
Mark Clemens, M.D., contributing author of the abstract added, "In conjunction with The PSF and the FDA, we have been conducting research and analyzing the incidence of BIA-ALCL to develop better understanding and effectively educate patients and physicians. This cutting edge research is an excellent example of the insights and advances that are unveiled at The Meeting. It is evidence of our role working to bring together the most leading-edge clinical information to enhance patient satisfaction and lead the way advancing patient safety."
PROFILE is just one clinical registry developed and managed by The PSF to garner and track important clinical data to optimize the safety and outcomes of plastic and reconstructive surgical procedures.
1Department of Plastic Surgery, M.D. Anderson Cancer Center
2Department of Plastic Surgery, M.D. Anderson Cancer Center
3Department of Plastic Surgery, M.D. Anderson Cancer Center
4Department of Surgical Oncology, M.D. Anderson Cancer Center
5Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
6Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center
7Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center
8Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
About ASPS
The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 11,000 physician members worldwide, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by the American Board of Plastic Surgery or the Royal College of Physicians and Surgeons of Canada.
About The PSF
The Plastic Surgery Foundation (The PSF), founded in 1948, supports research, international volunteer programs and visiting professor programs. The foundation's mission is to improve the quality of life of patients through research and development. The PSF accomplishes its mission by providing invaluable support to the research of plastic surgery sciences through a variety of grant programs. The PSF works in concert with the American Society of Plastic Surgeons (ASPS).
Media Contact
ASPS Media Relations
(847) 228-3333
media@plasticsurgery.org
Media Contact
ASPS Media Relations
(847) 228-3333
media@plasticsurgery.org
